MODULATORISCHE POLYNUKLEOTIDE

Patent europeic · EP3458588 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3458588
Numer da la dumonda
EP17800147
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
18-05-2017
Publitgà
27-03-2019
Concedì
29-10-2025
La protecziun finescha il pli tard
17-05-2037
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C12N 15/113 (2010.01)
C12N 15/85 (2006.01)
Prioritad
US 201662338137 P 18.05.2016
US 201762485050 P 13.04.2017
Dumonda PCT
PCT/US2017/033268 18.05.2017
Publicaziun PCT
WO2017/201248 23.11.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-09-2026

    Midada

    Published in Swissreg on 09.09.2026

  2. 01-06-2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. 26-01-2026

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 26.01.2026

  4. 29-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.10.2025

Partidas

Possessur

Voyager Therapeutics, Inc.

75 Hayden Ave., Lexington, Massachusetts 02421, US

Represchentant

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventur

SAH, Dinah Wen-Yee

Cambridge Massachusetts 02139, US

HOU, Jinzhao

Cambridge Massachusetts 02139, US

NONNENMACHER, Mathieu

Cambridge Massachusetts 02139, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.